English
|
Spanish
Supporting oncology professionals through education
Login
Register
The content on this site is intended for healthcare professionals only
Menu
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Latest news
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Journal information
Journal home
Charges
Editorial board
Founding editors
Editor-in-chief
Contact us
Author information
Submit article
Author guidelines
Editorial policies
Copyright information
Why publish with us
Reviewer information
Reviewer guidelines
Memberships
Videos
Recent videos
Sign up
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Conferences
Latest conferences
Sign up for latest coverage
Submit your event
About
e
cancer
About
e
cancer
Our founders
Funding statement
Contact us
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
e
cancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.
Please login or register. Then you can use this button to confirm you are part of this project.
Register for free
Already have an account?
Login
Videos
[1113]
News
[2404]
Articles
[143]
Editorials
[8]
Conferences
[99]
e
learning
[11]
ASCO GU 2022: Latest in mHSPC
Prof Eleni Efstathiou, Prof Karim Fizazi, Prof Kim Chi and Prof Matthew Smith
8 Mar 2022
ASCO GU 2022: PARP inhibitors in prostate and MAGNITUDE
Dr Neal Shore and Prof Kim Chi
4 Mar 2022
An AI-derived digital pathology-based biomarker to predict the benefit of ADT...
Prof Daniel Spratt - University Hospitals Seidman Cancer Center, Cleveland, USA
3 Mar 2022
SG in combination with pembro in patients with mUC who progressed after...
Dr Petros Grivas - Seattle Cancer Care Alliance, Seattle, USA
28 Feb 2022
NMIBC treated with IL-15RαFc superagonist N-803 and BCG infusion
Prof Sam Chang - Vanderbilt University School of Medicine, Nashville, USA
28 Feb 2022
Latest developments in mHSPC
Prof Kurt Miller and Prof Laura-Maria Krabbe
25 Feb 2022
Evaluating a polygenic hazard score to predict risk of developing metastatic or...
Dr Meghana Pagadala - University of California San Diego, San Diego, USA
25 Feb 2022
ASCO GU 2022: The latest in CRPC, including PARP combo data
Prof Eleni Efstathiou, Prof Gerhardt Attard, Prof Noel Clarke and Prof Axel...
25 Feb 2022
Atezolizumab with or without radiotherapy for advanced squamous cell carcinoma...
Dr Hielke Martijn de Vries - Netherlands Cancer Institute, Amsterdam, The...
24 Feb 2022
Update: Cabozantinib plus nivolumab demonstrates continued survival benefit in...
Dr Cristina Suárez - Vall d'Hebron Institute of Oncology (VHIO), Barcelona...
21 Feb 2022
KEYNOTE 564 update: Pembrolizumab versus placebo as post-nephrectomy adjuvant...
Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
21 Feb 2022
ASCO GU 2022: What to watch out for in renal
Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
21 Feb 2022
<
1
...
19
20
21
22
23
...
93
>
More from
e
cancer